Rock Creek Pharmaceuticals, Inc. Stock price

Equities

RCPIQ

US7720812046

Pharmaceuticals

Delayed OTC Markets 5-day change 1st Jan Change
- USD -.--% Intraday chart for Rock Creek Pharmaceuticals, Inc. -.--% -.--%
Sales 2014 - Sales 2015 - Capitalization 8.21M
Net income 2014 -38M Net income 2015 -6M EV / Sales 2014 -
Net cash position 2014 45K Net Debt 2015 19.86M EV / Sales 2015 -
P/E ratio 2014
-0.87 x
P/E ratio 2015
-1.04 x
Employees -
Yield 2014 *
-
Yield 2015
-
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Investor Relations Contact 46 12-04-17
More insiders
Rock Creek Pharmaceuticals Inc is a United States-based pharmaceutical development company. The Company is focused on the discovery, development and commercialization of therapies for chronic inflammatory disease and neurologic disorders. Its activities are focused on its lead compound, anatabine citrate (anatabine). Anatabine is a small molecule, cholinergic agonist, which exhibits anti-inflammatory pharmacological characteristics. The Company focuses on dermatological skin diseases, such as psoriasis, eczema and rare or orphan skin disorders, using its formulations of anatabine.
More about the company
  1. Stock
  2. Equities
  3. Stock Rock Creek Pharmaceuticals, Inc. - OTC Markets